PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

Nichole Andrews told Newsweek about a "sustainable, enjoyable, and scientifically supported for cancer risk reduction" diet.

An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...

Pancreatic cancer has recently been included in the list of diseases about which Brazil's National Cancer Institute (INCA) ...

Planegg/Martinsried, December 9, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor ...

The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small ...

A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...

Aflatoxin from primary smoke and ETS is the likely carcinogen, as these cancers are more often associated with tobacco use. Most recently, p53 mutations have been found in ETS lung cancer patients.

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Some common ... cause for lung cancer. Non-smokers can also develop lung cancer due to other factors like air pollution, radon gas exposure, secondhand smoke, and genetic mutations.

These mutations have enabled the development of targeted therapies ... Types Of Lung Cancer Common In Non-Smokers Dr Pandey explained that the most common lung cancer type in non-smokers is ...